Home » Topics » BioWorld Science

BioWorld Science
RSS

Metformin rejuvenates stem cells, restores CNS remyelination

Oct. 14, 2019

Aruna Bio receives support for preclinical development of AB-126

Oct. 11, 2019

PanOptica reports phase I/II topline data on PAN-90806 for wet AMD

Oct. 11, 2019

Aerpio releases phase Ib interim data on topical ocular formulation of AKB-9778

Oct. 11, 2019

OSE Immunotherapeutics' bispecific anti-PD-1/IL-7 fusion molecule tested in vitro and in vivo

Oct. 11, 2019

Kangpu completes first-in-human study of KPG-818

Oct. 11, 2019

MGB Biopharma completes first cohort in phase IIa study of MGB-BP-3 in CDAD

Oct. 11, 2019

NIH gives grant to Oligomerix to develop inhibitors of tau olgomer formation

Oct. 11, 2019

Potent new small-molecule inhibitors block apoptosis in mice

Oct. 11, 2019

Aurigene Discovery Technologies describes PRMT5 inhibitors

Oct. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...